Back to DEUTSCHE BANK AG\ DEUTSCHE BANK AG\

IKTIKT
4 quarters

Position history for DEUTSCHE BANK AG\DEUTSCHE BANK AG\'s holdings in INHIBIKASE THERAPEUTICS INC

DEUTSCHE BANK AG\ holds 126,677 shares of IKT (INHIBIKASE THERAPEUTICS INC), worth $257,154 as of 2026-Q2. The position was increased (+3.5% shares). IKT represents 0.0% of DEUTSCHE BANK AG\'s portfolio.

Current Value

$257,154

Current Shares

126,677

Total Value Change

+$126,750

Total Shares Change

+46,181

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
126,677
+3.5%
$257,1540.0%$2.03
24
2026-Q1
Increased
122,442
+123.0%
$205,7030.0%$1.91
37
2025-Q4
Decreased
54,909
-31.8%
$112,5630.0%$1.97
0
2025-Q3
New
80,496
-
$130,4040.0%$1.53
34

Other major holders of IKT: BlackRock, Inc., Blackstone Inc., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used